Sildenafil Citrate Tablet, Film Coated
Product Images NDC 68071-3592

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 68071-3592). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3592 9)

Pdp (68071 3592 9)
This is information about Sildenafil, a medication produced by NuCare Pharmaceuticals, Inc. The text includes details such as the dosage (25mg), lot number, manufacturer's details, and expiration date. Additionally, it provides instructions, warnings, and contact information for reporting side effects. It emphasizes keeping the medication out of reach of children and storing it at a controlled temperature of 68-77°F.*
FDA Label Image

Sildenafil_fig1.jpg (Sildenafil Fig1)

Sildenafil_fig1.jpg (Sildenafil Fig1)
This text provides a graph showing the mean change from baseline in sitting Systolic Blood Pressure in healthy volunteers over time post-dose for Sildenafil 100mg and placebo. The measurements are taken at Pre-Dose, 4, 8, 12, 16, and 20 hours post-dose.*
FDA Label Image

Sildenafil_fig3 (Sildenafil Fig 3)

FDA Label Image

Sildenafil_fig_4 (Sildenafil Fig 4)

FDA Label Image

Sidenafil_fig_5 (Sildenafil Fig 5)

Sidenafil_fig_5 (Sildenafil Fig 5)
This text is a figure caption mentioning the mean sildenafil plasma concentrations in healthy male volunteers. It is likely from a research study or a scientific report analyzing the levels of sildenafil in the blood of male participants.*
FDA Label Image

Sildenafil-fig7 (Sildenafil Fig7)

Sildenafil-fig7 (Sildenafil Fig7)
Percentage patients reporting improvement: - Placebo: 4% - Sidenail Tablets: 63% - Sideral Tablets: 24% Sitdari Tablets: 2%*
FDA Label Image

Str (Sildenafil Structure)

FDA Label Image

Figure2 (Sildenafil Fig2)

FDA Label Image

Sildenafil_fig6b (Sildenafil Fig6b)

FDA Label Image

Sildenafil_fig6a (Sildenafil Figure6a)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.